Cytokinetics reported $-108441000 in EBIT for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acadia Pharmaceuticals ACAD:US USD -30866000 2.78M
Amgen AMGN:US USD 2.66B 71M
Arca Biopharma ABIO:US USD -5680000 1.58M
Bayer BAYN:GR EUR 1.35B 928M
Biogen BIIB:US USD 872.1M 68.8M
Brainstorm Cell Therapeutics BCLI:US USD -6841000 750K
Bristol Myers Squibb BMY:US USD 2.74B 461M
Cytokinetics CYTK:US USD -108441000 97.57M
Eisai 4523:JP JPY -2181000000 9.62B
Eli Lilly And LLY:US USD 1.95B 294.9M
Exelixis EXEL:US USD 82.61M 1.09M
Genocea Biosciences GNCA:US USD -15773000 2.36M
Halozyme Therapeutics HALO:US USD 83.69M 49.63M
Intra Cellular Therapies ITCI:US USD -55629000 32.29M
Merk MRK:US USD 5.56B 156M
Novartis NOVN:VX USD 3.33B 8M
Pfizer PFE:US USD 9.7B 2.43B
Regeneron Pharmaceuticals REGN:US USD 1.22B 83.2M